Diagnos Laboratorium Utama Tbk. vs Surya Toto Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Surya Toto Indonesia Tbk. trades at Rp240 (market cap 2.48T, 843.1K 24h volume). The key difference: Surya Toto Indonesia Tbk. is far larger — about 8× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 843.1K). Which is the better fit depends on your goals.
| DGNS | TOTO | |
|---|---|---|
Market Cap | 310.75B | 2.48T |
Volume | 963.6K | 843.1K |
Lot | 9.64K | 8.43K |
Turnover | 217.67M | 199.91M |
Average Price | 225.89 | 237.12 |
Value | 217.67M | 199.91M |
Indicative Equilibrium Price | 226 | 240 |
Indicative Equilibrium Volume | 1K | 27 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Surya Toto Indonesia Tbk (the Company) was established on July 11, 1977 as a joint venture between three Indonesian company, PT Intimitra Sejahtera, PT Suryaparamitra Abadi and PT Multifortuna Asindo, and two Japanese companies, Toto Ltd., and Kashima Trading Company Ltd.
Read more on TOTO →